Ubiquitin ligase Cbl-b and inhibitory Cblin peptides

Biochim Biophys Acta Proteins Proteom. 2020 Nov;1868(11):140495. doi: 10.1016/j.bbapap.2020.140495. Epub 2020 Jul 12.

Abstract

This review focuses on the Cbl-b muscle atrophy-associated ubiquitin ligase and its inhibitors. Herein, the role of E3 ubiquitin ligase-associated muscle atrophy genes (atrogenes), including MAFbx-1/agrogin-1 and MuRF-1, as well as another ubiquitin ligase, Cbl-b and its inhibitors, is discussed. Cbl-b plays an important role in unloading muscle atrophy caused by spaceflight and in bedridden patients: Cbl-b ubiquitinated and induced the degradation of IRS-1, a key intermediate in the IGF-1 signaling. Furthermore, a pentapetpide (DGpYMP), inhibited Cbl-b-mediated IRS-1 ubiquitination. This peptide-based Cbl-b inhibitor Cblin and its homologous peptides in foods presumably affect muscle atrophy under such conditions.

Keywords: Cbl-b; Cblin; MAFbx-1/atrogin-1; MuRF-1; Muscle atrophy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / antagonists & inhibitors
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Humans
  • Muscular Atrophy / genetics
  • Oligopeptides / metabolism*
  • Proto-Oncogene Proteins c-cbl / antagonists & inhibitors
  • Proto-Oncogene Proteins c-cbl / genetics
  • Proto-Oncogene Proteins c-cbl / metabolism*
  • Ubiquitination

Substances

  • Adaptor Proteins, Signal Transducing
  • Oligopeptides
  • CBLB protein, human
  • Proto-Oncogene Proteins c-cbl